CSF3 and diffuse large B-cell lymphoma: G-CSF are recommended after the two main chemotherapy regimens used to treat DLBCL, namely R-CHOP and R-ACVB, and have been reported to induce increased uptake in the spleen and in the bone marrow [3], the latter also being affected by normal regeneration following chemotherapy.